Day: May 25, 2021

GUANGZHOU, China, May 25, 2021 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended March 31, 2021. Recent Business HighlightsEarly Detection  Launched the 11,873-subject PRESCIENT (Pan-canceR Early-Stage deteCtion by lIquid Biopsy tEchNique projecT) study for developing our 22-cancer early detection test. This is in addition to our ongoing PREDICT (Pan-CanceR Early DetectIon ProjeCT) study for the development of our 9-cancer early detection test. Presented at the 10th National Health Check-up Department Directors Summit (April 23 – April 25, 2021), where our early detection technology platform, product...

Transfer of HiPay Group shares to Euronext GrowthEffective transfer on 27 May 2021 Availability of the information document on the company’s website New mnemonic code: ALHYP ISIN code unchanged: FR0012821916  Paris, 25 May 2021: HiPay (ISIN code FR0012821916 – HIPAY), the fintech specialising in omnichannel payment solutions, announces the transfer of its shares to the Euronext Growth market, effective from the trading session of 27 May 2021.   This transfer to the Euronext Growth market aims to enable HiPay Group to be listed on a market better suited to the size of the company and its current market capitalisation. HiPay Group intends to benefit from a more flexible regulatory framework, while continuing to benefit from the advantages of the listing and the dynamism of Euronext Growth for all its shareholders. The proposed...

VANCOUVER, British Columbia and IRVINE, Calif., May 25, 2021 (GLOBE NEWSWIRE) — Clean Power Capital Corp. (NEO: MOVE)(FWB: 2K6)(OTC: MOTNF) (“Clean Power” or the “Company” or “MOVE”). Clean Power Capital is pleased to provide details regarding the innovative engineering solutions PowerTap is implementing to reduce the cost of producing a kilogram of hydrogen with its Gen3 unit. There are two general areas in which PowerTap is reducing production costs: 1) input costs; and 2) maintenance/downtime of the PowerTap Gen3 through innovative technology and engineering methods. Regarding the cost of inputs to the system, the three inputs into the system are electricity, renewable natural gas and water. Input Cost Reduction ElectricityPowerTap is reducing the cost of electricity in three ways – 1) incorporating electrochemical...

VANCOUVER, British Columbia, May 24, 2021 (GLOBE NEWSWIRE) — Swiss Water Decaffeinated Coffee Inc. (TSX – SWP) (“Swiss Water” or “the Company”) is pleased to announce an amendment to the existing senior debt facility with the Company’s senior lender, Business Development Bank of Canada, with participation by a new lender, Farm Credit Canada, which would provide the Company with up to an additional $25 million of senior debt financing at an interest rate of approximately four percent per annum and a favourable payment and amortization schedule by increasing the senior debt facility to $45 million from the current $20 million (the “Amended Senior Facility”). The incremental funds available under the Amended Senior Facility, together with the Company’s existing available credit and projected internally generated cash flow, are anticipated...

MANASSAS, Va., May 24, 2021 (GLOBE NEWSWIRE) — We are advised by Micron Technology, Inc. that journalists and other readers should disregard the news release, “Micron Hosts U.S. Secretary of Commerce, Congressional and Local Leaders at its State-of-the-Art Manassas, Virginia Fabrication Facility” issued at 6:24 p.m. PT, May 24, 2021, over GlobeNewswire. Please refer to the updated version issued at 8:15 p.m. PT, May 24, 2021. Updated version: https://investors.micron.com/news-releases/news-release-details/micron-hosts-us-secretary-commerce-and-congressional-and-local 

Micron Technology, Inc. hosted government officials for a tour of its Manassas, Va. advanced manufacturing facility.From L-R, Micron President and CEO Sanjay Mehrotra, U.S. Senator John Cornyn (R-TX), U.S. Secretary of Commerce Gina Raimondo, Manassas Mayor Michelle Davis-Younger and U.S. Senator Mark R. Warner (D-VA).MANASSAS, Va., May 24, 2021 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU), today hosted U.S. Secretary of Commerce Gina Raimondo and Congressional and local officials for a tour of its Manassas, Va., advanced manufacturing facility. The visit underscored the importance of domestic semiconductor manufacturers, and highlighted Micron’s position in the industry as the only manufacturer of memory and storage products in the U.S. Secretary Raimondo was joined by U.S. Senators John Cornyn (R-TX)...

Micron Technology, Inc. hosted government officials for a tour of its Manassas, Va. advanced manufacturing facility.Micron Technology, Inc. hosted government officials for a tour of its Manassas, Va. advanced manufacturing facility. From L-R, Micron President and CEO Sanjay Mehrotra, Senator John Cornyn (R-TX), U.S. Secretary of Commerce Gina Raimondo, Manassas Mayor Michelle Davis-Younger and Senator Mark Warner (D-VA).MANASSAS, Va., May 24, 2021 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU), today hosted U.S. government officials for a tour of its Manassas, VA, advanced manufacturing facility. The visit underscored the importance of Micron’s position in the industry as the only manufacturer of memory and storage products in the U.S. In attendance were Secretary of Commerce Gina Raimondo, Senators...

MELBOURNE, Australia and KYOTO, Japan, May 25, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a clinical study in Japan using Telix’s investigational prostate cancer imaging product TLX591-CDx (Illuccix®, Kit for the preparation of 68Ga-PSMA-11 injection). The study is an academic collaboration between Telix and Kanazawa University. The study will enroll ten patients with advanced prostate cancer and is the first clinical evaluation of gallium-based PSMA imaging in Japan. The objective is to obtain safety data in a representative Japanese patient population, and to demonstrate that the targeting and biodistribution of TLX591-CDx in Japanese patients is consistent with international experience. Clinical data may facilitate development...

MELBOURNE, Australia and SOUTHAMPTON, United Kingdom, May 25, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Company’s bone marrow conditioning investigational candidate TLX66 (90Y-besilesomab) has met study objectives, demonstrating the initial safety profile in patients with Systemic Amyloid Light Chain Amyloidosis (AL amyloidosis). The TRALA trial (Targeted Radiotherapy for AL Amyloidosis) is a Phase I/IIa trial to evaluate the safety and toxicity of TLX66 as the sole bone marrow conditioning agent prior to autologous hematopoietic stem cell transplantation (HSCT) in patients with AL amyloidosis.1 The TRALA trial was sponsored by University Hospital Southampton in Southampton U.K. and run across four centres: Southampton, University College Hospital London, Royal...

PEMBROKE, Bermuda, May 24, 2021 (GLOBE NEWSWIRE) — Sompo International Holdings Ltd., a Bermuda-based specialty provider of property and casualty insurance and reinsurance, announced today that after 8 years with the company and over five decades of unparalleled success in the industry, John Charman will retire from Sompo International at the end of his current contract in April 2022. James Shea has been selected to succeed Mr. Charman in his role of Executive Chairman of the Board of Directors, Sompo International Holdings Ltd. and Chief Executive Officer of Overseas Insurance and Reinsurance Business, Sompo Holdings, Inc. In addition, he will be appointed Chief Executive Officer of Sompo International Holdings. All of Mr. Shea’s appointments will be effective September 1, 2021, subject to regulatory approvals. He will report...